Hague

Netherlands

4 total trials

Filter these 4 trials by phase, condition, sponsor and more.

Open in Search →

HOVON 164 HL: Tislelizumab plus Gemcitabine and Cisplatin for Relapsed or Refractory Hodgkin Lymphoma followed by Tislelizumab Consolidation … Ended recruitment

2022-502225-17-00 4 2023-07-14 Hodgkin lymphoma
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended recruitment

2022-502478-18-00 4 2019-12-20 Acute Myeloid Leukemia (AML)
HOVON 151 DLBCL: A phase II study evaluating the feasibility and clinical efficacy of atezolizumab consolidation treatment in high risk diff … Ended recruitment

2022-501076-26-00 4 2018-08-28 high risk diffuse large B-cell lymphoma
HOVON 152 DLBCL. A phase II study evaluating the effect of DA-EPOCH-R induction followed by nivolumab consolidation in patients with newly d … Ended recruitment

2022-501038-48-00 4 2018-07-26 Diffuse Large B-Cell Lymphoma

Showing 1–4 of 4 trials